Variations in CTH gene activity, which regulates cysteine production and thus influences glutathione synthesis, may affect the detoxification of the chemotherapy drugs busulfan and cyclophosphamide. This altered glutathione level, critical for handling oxidative stress, can consequently impact the drugs' toxicity and effectiveness.